Moisturizers for Skin Dryness in Cancer

This trial explores whether certain moisturizers can reduce skin dryness in cancer patients experiencing skin problems from their treatments. Participants will apply specific La Roche Posay products daily to assess improvements in their skin condition. The trial includes a few clinic visits for skin evaluations and tests before and after product use. Suitable candidates have cancer, are currently receiving treatment, and are experiencing related skin issues.

As an unphased trial, this study provides a unique opportunity to potentially improve skin health while contributing to valuable research.

Studies have shown that the La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream is safe for sensitive skin. Dermatologists have tested it, confirming its safety for the whole family, including those undergoing chemotherapy and radiation. This cream contains no fragrances or parabens and has undergone allergy testing.

The La Roche Posay Cicaplast balm with Panthenol/Vitamin B5 is also part of the study, but specific safety details are unavailable from the sources provided.

The Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash is proven safe for sensitive skin, even for babies as young as two weeks. It is fragrance-free and soap-free, tested by dermatologists, and gentle on dry and sensitive skin.

Researchers are excited about these moisturizers for skin dryness in cancer patients because they incorporate active ingredients like Panthenol/Vitamin B5, which is known for its soothing properties and skin barrier repair capabilities. Unlike typical moisturizers, these products are specifically designed for atopy-prone skin, offering a targeted approach that addresses the unique needs of skin affected by cancer treatments. Additionally, the combination of a specialized face and body wash and a triple repair cream provides a comprehensive skincare regimen that is gentle yet effective, potentially offering relief and improvement in skin condition faster than standard options.

Research has shown that La Roche-Posay Cicaplast Balm B5 effectively aids in skin healing and hydration. Over 96% of users report that it soothes dry and irritated skin, particularly benefiting those undergoing cancer treatments. Participants in this trial will incorporate La Roche-Posay Cicaplast Balm B5 into their regimen.

The La Roche-Posay Lipikar AP+ Triple Repair Moisturizing Cream, also part of the trial regimen, has been proven to help very dry skin stay hydrated for up to 48 hours and is safe for individuals receiving chemotherapy. It is specifically formulated for dry, itchy, and eczema-prone skin.